Al Jehani Ayah Nabil, Shuaib Manal, Alsharif Arwa, Alsubaie Khlood Abdulaziz, Khraisat Ayda, Alsharif Abdulaziz, Altaf Manaf, Almasry Ruba H, Kayali Amal Mohamed, Abdallah Shouq Abdin
College of Medicine and Surgery, Batterjee Medical College, Jeddah 21442, Saudi Arabia.
College of Medicine and Surgery, Vision College, Jeddah 23643, Saudi Arabia.
Pediatr Rep. 2025 Jun 17;17(3):67. doi: 10.3390/pediatric17030067.
: The maternal microbiota serve as a key regulator of neonatal immune development and early-life health outcomes. This systematic review aims to find out how the makeup of the maternal microbiota affects newborn immunity and the risk of allergies, identify which microbes are linked to a higher or lower chance of allergies, and assess treatments that could improve newborn immune health. : We conducted a systematic search in PubMed, MEDLINE, and Web of Science, adhering to the PRISMA guidelines. We included randomized controlled trials (RCTs), cohort studies, and observational studies that looked at how the makeup of the maternal microbiota affects newborn immune responses or allergic outcomes in early life. We conducted a systematic search, and the quality of the studies was evaluated using the GRADE system and tools to check for bias (RoB 2, Newcastle-Ottawa Scale, MINORS). : We included a total of 74 studies. The main findings showed that having a cesarean delivery and using certain antibiotics during pregnancy increased the risk of allergies, while breastfeeding, taking probiotics, and changing the mother's diet helped to protect against allergies. Maternal stress had a negative association with the microbiota composition (OR = 1.9-2.4) and neonatal immune regulation. Moreover, the study noted significant geographic variation in the microbiota's influence, underscoring the importance of contextualized interventions. : The composition of the maternal microbiota has a major impact on neonatal immunity and the risk of early-life allergy. Adverse factors include cesarean birth, antibiotic exposure, and maternal stress, all of which have been associated with alterations in neonatal immunity. More studies are required to validate promising microbiota-targeted strategies and develop evidence-based guidelines to improve maternal and neonatal immune health.
母体微生物群是新生儿免疫发育和早期健康结果的关键调节因子。本系统综述旨在探究母体微生物群的组成如何影响新生儿免疫和过敏风险,确定哪些微生物与过敏的高风险或低风险相关,并评估可改善新生儿免疫健康的治疗方法。
我们按照PRISMA指南在PubMed、MEDLINE和科学网进行了系统检索。我们纳入了随机对照试验(RCT)、队列研究和观察性研究,这些研究关注母体微生物群的组成如何影响新生儿早期的免疫反应或过敏结局。我们进行了系统检索,并使用GRADE系统和工具(RoB 2、纽卡斯尔-渥太华量表、MINORS)评估研究质量。
我们共纳入了74项研究。主要研究结果表明,剖宫产和孕期使用某些抗生素会增加过敏风险,而母乳喂养、服用益生菌和改变母亲饮食有助于预防过敏。母体压力与微生物群组成(OR = 1.9 - 2.4)和新生儿免疫调节呈负相关。此外,该研究指出微生物群影响存在显著的地理差异,强调了因地制宜干预措施的重要性。
母体微生物群的组成对新生儿免疫和早期过敏风险有重大影响。不利因素包括剖宫产、接触抗生素和母体压力,所有这些都与新生儿免疫改变有关。需要更多研究来验证有前景的针对微生物群的策略,并制定基于证据的指南以改善母婴免疫健康。